Please assess the completion status of the following clinical trial:

Trial Title: Validation of a Real-time Urodynamic Measure of Urinary Urgency

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Have symptoms of urge or mixed incontinence (urge predominant) and desire treatment with anticholinergic medication.~* Demonstrated detrusor overactivity with or without incontinence during urodynamic testing.~* Are able to consent and fill out study documents, complete repeated urodynamic testing, and follow-up in 4 weeks.~Exclusion Criteria:~* Have been treated with any anticholinergic medication in the previous month.~* Have an elevated post -void residual volume as determined during their routine clinical care.~* Have had a urinary tract infection in the last month, as determined by history.~* Have untreated narrow angle glaucoma, by patient history.~* Have a known allergy or intolerance to solifenacin, as determined by patient history.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Solifenacin Succinate (Type: EXPERIMENTAL): The intervention for this study is 10mg daily solifenacin. Patients with overactive bladder syndrome will take this study drug for 30 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).